論文

2019 英文

TITLE & JOURNAL/AUTHORS

• Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis.
  著者名：Honda A, Tanaka A, Kaneko T, Komori A, Abe M, Inao M, Namisaki T, Hashimoto N, Kawata K, Takahashi A, Ninomiya M, Kang JH, Arakawa M, Yamagiwa S, Joshita S, Umemura T, Sato K, Kaneko A, Kikuchi K, Itakura J, Nomura T, Kakisaka K, Fujii H, Kawada N, Takikawa Y, Masaki T, Ohira H, Mochida S, Yoshiji H, Iimuro S, Matsuzaki Y, Takikawa H; Japan PBC Study Group (JPBCSG).
  出版物名：Hepatology. 2019 Feb 8. doi: 10.1002/hep.30552.
• Switching to tenofovir disoproxil fumarate vs continuing treatment in patients with chronic hepatitis B who maintain long-term virological response to entecavir therapy: A randomized trial.
  著者名：Iida-Ueno A, Enomoto M, Kozuka R, Tamori A, Kawada N.
  出版物名：J Med Virol. 2019 Jul;91(7):1295-1300. doi: 10.1002/jmv.25442. Epub 2019 Mar 12.
• Obesity and hiatal hernia may be non-allergic risk factors for esophageal eosinophilia in Japanese adults.
  著者名：Tanaka F, Fukumoto S, Morisaki T, Otani K, Hosomi S, Nagami Y, Kamata N, Taira K, Nakano A, Kimura T, Yamagami H, Tanigawa T, Morikawa H, Watanabe T, Kawada N, Hirata K, Fujiwara Y.
  出版物名：Esophagus. 2019 Jul;16(3):309-315. doi: 10.1007/s10388-019-00662-3. Epub 2019 Mar 29.
• Last crusade against HCV: Direct-acting antiviral treatment for marginalized populations.
  著者名：Fujii H, Enomoto M, Murakami Y, Hagihara A, Kawada N, Saito S.
  出版物名：J Viral Hepat. 2019 Aug 14. doi: 10.1111/jvh.13190.
• Intention-to-treat assessment of glecaprevir + pibrentasvir combination therapy for patients with chronic hepatitis C in the real world.
  著者名：Tamori A, Inoue K, Kagawa T, Takaguchi K, Nouso K, Iwasaki Y, Minami M, Hai H, Enomoto M, Kawada N.
  出版物名：Hepatol Res. 2019 Jul 19. doi: 10.1111/hepr.13410
• Hepatitis C virus recurrence in two patients who achieved sustained viral response with interferon-free direct-acting antiviral therapy: reinfection or relapse?
  著者名：Yukawa Y, Tamori A, Iio E, Ogawa S, Yoshida K, Uchida-Kobayashi S, Enomoto M, Tanaka Y, Kawada N.
  出版物名：Clin J Gastroenterol. 2019 Jun 4. doi: 10.1007/s12328-019-01001-w
• Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma.
  著者名：Kotani K, Enomoto M, Okada M, Yoshida K, Motoyama H, Fujii H, Hagihara A, Uchida-Kobayashi S, Morikawa H, Murakami Y, Tamori A, Kawada N.
  出版物名：Clin J Gastroenterol. 2019 Aug;12(4):355-360. doi: 10.1007/s12328-019-00983-x. Epub 2019 Apr 24.
• Role of the Gut-Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship.
  著者名：Ohtani N, Kawada N.
  出版物名：Hepatol Commun. 2019 Mar 1;3(4):456-470. doi: 10.1002/hep4.1331. eCollection 2019 Apr. Review.
• HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
  著者名：Fujii H, Imajo K, Yoneda M, Nakahara T, Hyogo H, Takahashi H, Hara T, Tanaka S, Sumida Y, Eguchi Y, Chayama K, Nakajima A, Nishimoto N, Kawada N; Japan Study Group of Nonalcoholic Fatty Liver Disease.
  出版物名：J Gastroenterol Hepatol. 2019 Aug;34(8):1390-1395. doi: 10.1111/jgh.14595. Epub 2019 Feb 3.
• Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
  著者名：Ji F, Yeo YH, Wei MT, Ogawa E, Enomoto M, Lee DH, Iio E, Lubel J, Wang W, Wei B, Ide T, Preda CM, Conti F, Minami T, Bielen R, Sezaki H, Barone M, Kolly P, Chu PS, Virlogeux V, Eurich D, Henry L, Bass MB, Kanai T, Dang S, Li Z, Dufour JF, Zoulim F, Andreone P, Cheung RC, Tanaka Y, Furusyo N, Toyoda H, Tamori A, Nguyen MH.
  出版物名：J Hepatol. 2019 Sep;71(3):473-485. doi: 10.1016/j.jhep.2019.04.017. Epub 2019 May 13.
• Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium.
  著者名：Huang CF, Iio E, Jun DW, Ogawa E, Toyoda H, Hsu YC, Haga H, Iwane S, Enomoto M, Lee DH, Wong G, Liu CH, Tada T, Chuang WL, Cheung R, Hayashi J, Tseng CH, Yasuda S, Tran S, Kam L, Henry L, Jeong JY, Nomura H, Park SH, Nakamuta M, Huang JF, Tai CM, Lo GH, Lee MH, Yang HI, Kao JH, Tamori A, Eguchi Y, Ueno Y, Furusyo N, Tanaka Y, Yu ML, Nguyen MH; REAL-C Investigators.
  出版物名：Hepatol Int. 2019 Sep;13(5):587-598. doi: 10.1007/s12072-019-09974-z. Epub 2019 Aug 28.
• REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy.
  著者名：Yang HI, Yeh ML, Wong GL, Peng CY, Chen CH, Trinh HN, Cheung KS, Xie Q, Su TH, Kozuka R, Lee DH, Ogawa E, Zhao C, Ning HB, Huang R, Li J, Zhang JQ, Ide T, Xing H, Iwane S, Takahashi H, Wong C, Wong C, Lin CH, Hoang J, le A, Henry L, Toyoda H, Ueno Y, Gane EJ, Eguchi Y, Kurosaki M, Wu C, Liu C, Shang J, Furusyo N, Enomoto M, Kao JH, Yuen MF, Yu ML, Nguyen MH.
  出版物名：J Infect Dis. 2019 Sep 24. pii: jiz477. doi: 10.1093/infdis/jiz477.
• Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West.
  著者名：Dang H, Yeo YH, Yasuda S, Huang CF, Iio E, Landis C, Jun DW, Enomoto M, Ogawa E, Tsai PC, Le A, Liu M, Maeda M, Nguyen B, Ramrakhiani N, Henry L, Cheung R, Tamori A, Kumada T, Tanaka Y, Yu ML, Toyoda H, Nguyen MH.
  出版物名：Hepatology. 2019 Oct 14. doi: 10.1002/hep.30988.
• Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.
  著者名：Hsu YC, Wong GL, Chen CH, Peng CY, Yeh ML, Cheung KS, Toyoda H, Huang CF, Trinh H, Xie Q, Enomoto M, Liu L, Yasuda S, Tanaka Y, Kozuka R, Tsai PC, Huang YT, Wong C, Huang R, Jang TY, Hoang J, Yang HI, Li J, Lee DH, Takahashi H, Zhang JQ, Ogawa E, Zhao C, Liu C, Furusyo N, Eguchi Y, Wong C, Wu C, Kumada T, Yuen MF, Yu ML, Nguyen MH.
  出版物名：Am J Gastroenterol. 2019 Oct 11. doi: 10.14309/ajg.0000000000000428.
• Circulating Exosomal miRNA Profiles Predict the Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with Direct-Acting Antiviral-Induced Sustained Viral Response.
  著者名：Itami-Matsumoto S, Hayakawa M, Uchida-Kobayashi S, Enomoto M, Tamori A, Mizuno K, Toyoda H, Tamura T, Akutsu T, Ochiya T, Kawada N, Murakami Y.
  出版物名：Biomedicines. 2019 Nov 3;7(4). pii: E87. doi: 10.3390/biomedicines7040087.
• Association between Functional Dyspepsia and Gastric Depressive Erosions in Japanese Subjects.
  著者名：Tanaka F, Tominaga K, Fujikawa Y, Morisaki T, Otani K, Hosomi S, Nagami Y, Kamata N, Taira K, Nakano A, Kimura T, Yamagami H, Tanigawa T, Morikawa H, Fukumoto S, Watanabe T, Kawada N, Hirata K, Fujiwara Y.
  出版物名：Intern Med. 2019 Feb 1;58(3):321-328. doi: 10.2169/internalmedicine.1325-18
• Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.
  著者名：Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, Li X, Chien N, Wei M, Ogawa E, Zhao C, Wu X, Stave CD, Henry L, Barnett S, Takahashi H, Furusyo N, Eguchi Y, Hsu YC, Lee TY, Ren W, Qin C, Jun DW, Toyoda H, Wong VW, Cheung R, Zhu Q, Nguyen MH.
  出版物名：Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1

2019 和文

タイトル・著者

• 【肝臓病学の未来-ウイルス性肝炎から脂肪肝と肝がんの時代へ】C型肝炎　HCV排除は肝がんを抑制するのか　外来でのフォローはどうするか(解説/特集)
  著者名：榎本 大(大阪市立大学 大学院医学研究科肝胆膵病態内科学)、伊倉 義弘、田守 昭博、河田 則文
  出版物名：内科 (0022-1961)123巻5号 Page1081-1085(2019.05)
• 『消化器の臨床』門脈圧亢進症
  著者名：元山 宏行、河田 則文
  出版物名：「消化器の臨床」Vol.21 No.3 2018
• 肝機能障害を契機に診断されたサルコイドーシス5例の検討
  著者名：焦 光裕、榎本 大、小谷 晃平、小田 桐直志、吉田 香奈子、元山 宏行、小塚 立蔵、藤井 英樹、萩原 淳司、打田 佐和子、森川 浩安、村上 善基、田守 昭博、河田 則文
  出版物名：肝臓60巻11号　405-413
• 肝星細胞の活性化の仕組み　サイトグロビンの作用から見えてくる新しい視点(解説/特集)
  著者名：松原 三佐子、河田 則文、吉里 勝利
  出版物名：細胞 (1346-7557)51巻11号 Page530-534(2019.10)